Johnson & Johnson is accelerating trials of its Covid-19 vaccine in what its chief scientific officer calls “a race against time” – and against a potential second wave of the virus.
Johnson & Johnson is accelerating trials of its Covid-19 vaccine in what its chief scientific officer calls “a race against time” – and against a potential second wave of the virus.